Pharmaceutical Tariff Exemption Is No End to Cost Threat
By Dan McKay · April 8, 2025, 4:51 PM EDT
The life sciences industry escaped much of the immediate impact of President Donald Trump's market-shaking tariff order, thanks to the inclusion of a single word on an exemption list — "pharmaceuticals."...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login